Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
A Long-Term Follow-Up Study Using IPMSSG Criteria in Children With CNS Demyelination.
Preference-based Health status in a German outpatient cohort with multiple sclerosis.
EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls.
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
Motor network efficiency and disability in multiple sclerosis.
Do coping styles mediate the relationship between disability status and psychosocial loss in people with relapsing remitting multiple sclerosis?
Discovering Gene Regulatory Elements Using Coverage-based Heuristics.
Ventricular arrhythmia in a male MS patient on fingolimod.
Cigarette smoke inhibits efferocytosis via deregulation of sphingosine kinase signaling: reversal with exogenous S1P and the S1P analogue FTY720.
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
Cholesterol in myelin biogenesis and hypomyelinating disorders.
Multiple sclerosis and pregnancy prescriptions.
Acute disseminated encephalomyelitis: current knowledge and open questions.
Restoring nervous system structure and function using tissue engineered living scaffolds.
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits.
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Diffusion-weighted imaging thermometry in multiple sclerosis.
Diminished schwann cell repair responses underlie age-associated impaired axonal regeneration.
Volumetric MRI assessment of brain and spinal cord in finnish twins discordant for multiple sclerosis.
Pages
« first
‹ previous
…
575
576
577
578
579
580
581
582
583
…
next ›
last »